REPLIGEN CORP Interest Income (Expense), Net
REPLIGEN CORP (RGEN) reported Interest Income (Expense), Net of -$12.00 thousand for the 3-month period ending 2014-12-31, per its 10-K filed 2015-03-17.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2015-03-17
- REPLIGEN CORP interest income (expense), net for the quarter ending 2014-12-31 was -$12.00K.
- REPLIGEN CORP interest income (expense), net for the quarter ending 2014-09-30 was -$11.00K.
- REPLIGEN CORP interest income (expense), net for the quarter ending 2014-06-30 was -$13.00K.
- REPLIGEN CORP interest income (expense), net for the quarter ending 2014-03-31 was -$14.00K.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2014-12-31 | -$12.00K 10-K · filed 2015-03-17 | -$23.00K derived: sum of 2 quarters · filed 2015-03-17 | -$36.00K derived: sum of 3 quarters · filed 2015-03-17 | -$50.00K derived: sum of 4 quarters · filed 2015-03-17 |
| 2014-09-30 | -$11.00K 10-K · filed 2015-03-17 | -$24.00K derived: sum of 2 quarters · filed 2015-03-17 | -$38.00K derived: sum of 3 quarters · filed 2015-03-17 | -$50.00K derived: sum of 4 quarters · filed 2015-03-17 |
| 2014-06-30 | -$13.00K 10-K · filed 2015-03-17 | -$27.00K derived: sum of 2 quarters · filed 2015-03-17 | -$39.00K derived: sum of 3 quarters · filed 2015-03-17 | -$51.00K derived: sum of 4 quarters · filed 2015-03-17 |
| 2014-03-31 | -$14.00K 10-K · filed 2015-03-17 | -$26.00K derived: sum of 2 quarters · filed 2015-03-17 | -$38.00K derived: sum of 3 quarters · filed 2015-03-17 | -$50.00K derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-12-31 | -$12.00K 10-K · filed 2015-03-17 | -$24.00K derived: sum of 2 quarters · filed 2015-03-17 | -$36.00K derived: sum of 3 quarters · filed 2015-03-17 | -$50.00K derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-09-30 | -$12.00K 10-K · filed 2015-03-17 | -$24.00K derived: sum of 2 quarters · filed 2015-03-17 | -$38.00K derived: sum of 3 quarters · filed 2015-03-17 | -$52.00K derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-06-30 | -$12.00K 10-K · filed 2015-03-17 | -$26.00K derived: sum of 2 quarters · filed 2015-03-17 | -$40.00K derived: sum of 3 quarters · filed 2015-03-17 | -$33.00K derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-03-31 | -$14.00K 10-K · filed 2015-03-17 | -$28.00K derived: sum of 2 quarters · filed 2015-03-17 | -$21.00K derived: sum of 3 quarters · filed 2015-03-17 | -$48.00K derived: sum of 4 quarters · filed 2015-03-17 |
| 2012-12-31 | -$14.00K 10-K · filed 2014-03-14 | -$7.00K derived: sum of 2 quarters · filed 2014-03-14 | -$34.00K derived: sum of 3 quarters · filed 2014-03-14 | -$56.00K derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-09-30 | $7.00K 10-K · filed 2014-03-14 | -$20.00K derived: sum of 2 quarters · filed 2014-03-14 | -$42.00K derived: sum of 3 quarters · filed 2014-03-14 | |
| 2012-06-30 | -$27.00K 10-K · filed 2014-03-14 | -$49.00K derived: sum of 2 quarters · filed 2014-03-14 | ||
| 2012-03-31 | -$22.00K 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |